Skip to content
    Continental Grain Company logo

    Continental Grain Company

    New York, New York, United StatesFounded 1813
    continentalgrain.comLinkedIn
    Food & Agriculture

    Continental Grain Company (Conti) is a privately-owned global investor, owner, and operator of companies across the food, agribusiness, and commodities spectrum. With a history dating back to 1813, the firm deploys both private and permanent capital across the food value chain, from protein and animal feed to food processing, manufacturing, and retail.

    50% of their portfolio is in Food & Agriculture. Average disclosed round size is $36.6M (across 19 rounds with reported amounts).

    Find people at Continental Grain Company on Goldilocks AI

    Portfolio

    13

    Fund Size

    —

    Top Stage

    Series C

    Last 12 Mo

    0

    Team

    IS

    Ignacio Sanz

    Principal of Conti Direct Investments

    SB

    Suyash Bulchandani

    Vice President, Investment Team - Consumer

    JM

    Joe Magliano

    Private Equity Investor

    BL

    Brian Loeb

    Co-Head, Conti Ventures

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    20 investments
    CompanyRoundAmountDate
    Sentera logoSenteraSeries C—May 2023
    MycoTechnology logoMycoTechnologySeries E$85MMar 2022
    DMC logoDMCSeries B$39MJan 2022
    Sentera logoSenteraSeries C$25MJun 2021
    Ukko logoUkkoSeries B$40MJan 2021
    EAVision logoEAVisionSeries C$30MJan 2021
    MycoTechnology logoMycoTechnologySeries D$39MJun 2020
    Phospholutions logoPhospholutionsSeed$1.5MJun 2019
    MycoTechnology logoMycoTechnologySeries C$30MJan 2019
    GreenLight Biosciences, Inc. logoGreenLight Biosciences, Inc.Unknown$50MJan 2019
    Sentera logoSenteraSeries A$14MSep 2018
    EEvolve BiosystemsSeries C$40MJun 2018
    MycoTechnology logoMycoTechnologySeries B$42MOct 2017
    Restaurant Technologies logoRestaurant TechnologiesUnknown$60M—
    Bushel logoBushelUnknown$26M—
    PPrenexus HealthSeries B$23M—
    MycoTechnology logoMycoTechnologySeries E$85M—
    EAVision logoEAVisionUnknown$30M—
    Phospholutions logoPhospholutionsSeries A$10.3M—
    PPerfect Day Inc.Series A$24.7M—

    Top Co-Investors

    S2G Ventures8 shared
    Gaingels5 shared
    Middleland Capital5 shared
    Eighteen94 Capital3 shared
    iSelect Fund3 shared
    Temasek Holdings (Private) Limited3 shared
    PeakBridge2 shared
    Sony Innovation Fund2 shared
    La Caisse2 shared
    Evolution Equity Partners2 shared
    Siddhi Capital2 shared
    BASF Venture Capital2 shared
    Bits x Bites2 shared
    Tyson Ventures2 shared
    Seventure Partners2 shared
    Tao Capital Partners2 shared
    HL Ventures2 shared
    Tess Ventures1 shared
    Innovation Endeavors1 shared
    Leaps by Bayer1 shared

    Last updated: 7 October 2026